Literature DB >> 7888691

Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism.

M J Koistinen1, H V Huikuri, U R Korhonen, M K Linnaluoto, T Kuusi, J T Takkunen, M R Taskinen.   

Abstract

The risk factors for asymptomatic coronary artery disease (CAD) were examined in 138 diabetic patients. Following non-invasive screening examinations (exercise electrocardiography, dynamic thallium scintigraphy, 24-h electrocardiographic recording), CAD was confirmed angiographically in 21 symptom-free diabetic subjects with an ischaemic finding in at least one of the non-invasive tests. The prevalence of asymptomatic CAD in this cohort of diabetic patients was 21/132 (16%), which may be an underestimation because 6 patients refused angiography. Risk factors (age, diabetes, smoking, hypertension, serum lipoproteins, apoproteins and apo E phenotypes) were analysed according to the presence or absence of CAD. Multivariate logistic stepwise analysis did not show any definite changes of serum lipids, lipoproteins and apoproteins in type 1 (n = 72) and type 2 (n = 66) diabetic patients with or without asymptomatic CAD. The only factors associated with asymptomatic CAD were the duration of diabetes (P < 0.005) and the age of the patient (P < 0.05). These results suggest that in diabetic patients the major risk factor for premature coronary atherosclerosis is diabetes itself. Assessment of other risk factors does not seem to define any subgroup with asymptomatic CAD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888691     DOI: 10.1007/bf00571953

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  22 in total

Review 1.  Diabetic macrovascular disease and serum lipids: is there a connection?

Authors:  P K Merrin; M D Feher; R S Elkeles
Journal:  Diabet Med       Date:  1992 Jan-Feb       Impact factor: 4.359

2.  Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

Authors:  J S Yudkin; R D Forrest; C A Jackson
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Stress exercise testing of the young diabetic for the detection of unknown coronary artery disease.

Authors:  I M Levitas; J J Kristal
Journal:  Isr J Med Sci       Date:  1972-06

5.  Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival.

Authors:  J O Partamian; R F Bradley
Journal:  N Engl J Med       Date:  1965-08-26       Impact factor: 91.245

Review 6.  Diabetic vascular disease.

Authors:  K R Feingold; M D Siperstein
Journal:  Adv Intern Med       Date:  1986

7.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

8.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

9.  Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.

Authors:  T Rönnemaa; M Laakso; V Kallio; K Pyörälä; J Marniemi; P Puukka
Journal:  Am J Epidemiol       Date:  1989-10       Impact factor: 4.897

10.  Prevalence of diabetic complications in relation to risk factors.

Authors:  M W Knuiman; T A Welborn; V J McCann; K G Stanton; I J Constable
Journal:  Diabetes       Date:  1986-12       Impact factor: 9.461

View more
  3 in total

1.  Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

Authors:  Yasuaki Hayashino; Sizuko Nagata-Kobayashi; Takeshi Morimoto; Kenji Maeda; Takuro Shimbo; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

2.  Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism.

Authors:  Carmine Gazzaruso; Adriana Garzaniti; Stefano Giordanetti; Colomba Falcone; Pietro Fratino
Journal:  Cardiovasc Diabetol       Date:  2002-11-22       Impact factor: 9.951

Review 3.  Excess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk?

Authors:  Sunita Dodani
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.